HMM304 - Therapeutic Development
Unit details
| Enrolment modes: | (G) |
|---|---|
| Credit point(s): | 1 |
| EFTSL value: | 0.125 |
| Unit chair: | Y Gibert (G) |
| Prerequisite: | HMM301 |
| Contact hours: | 3 x 1 hour lectures per week, and as online exercises, case studies, debates and discussions |
Note:Unit commences in 2014 Online teaching methods require internet access. Please refer to the most current computer specifications. | |
Content
This unit describes how therapeutic targets are identified and how new therapies are developed for human use. It will provide an overview of the major therapeutic classes, including synthetic compounds, natural products, vaccines, nutriceuticals and other biological agents, and covers the therapeutic development pipeline, encompassing target identification and validation, therapeutic discovery and development, pre-clinical trials and toxicity testing.
Assessment
Mid-semester test (45 minutes) 20%, written report (1200 words) 25%, case study (1200 words) 25%, examination (2 hours) 30%
Prescribed texts
Rang HP. 2006. Drug Discovery and Development: Technology in Transition. 1st Ed. Churchill Livingstone, Edinburgh, UK